ABSTRACT Two extraction steps combined with HPLC with fluorescence detection were developed to determine the toxicokinetics of fumonisin B 2 (FB 2 ) in ducks and turkeys. The limit of quantification of the method was 25 ng of FB 2 /mL. The mean extraction was 63%. After intravenous administration (single dose: 1 mg of FB 2 /kg of BW), plasma concentration time curves were best described by a 2-compartment open model. In ducks, elimination half-life, mean residence time, and clearance of FB 2 were 32 min, 12.9 min, and 9.3 mL/min per kilogram, respectively. In turkeys, these toxicokinetics parameters were 12.4 min, 5 min, and 8.7 mL/min per kilogram, respectively. Only a small amount of FB 2 was detected in plasma after oral dosing of 10 mg of FB 2 /kg of BW.
INTRODUCTION
Fumonisins are mycotoxins produced by Fusarium verticillioïdes and Fusarium proliferatum (International Programme on Chemical Safety, 2000) , which are found worldwide in maize and maize products. In farm animals, equine leukoencephalomalacia and porcine pulmonary edema are 2 syndromes known to be caused by fumonisins. Hepatic and renal toxicity can be observed in several species, including broilers, turkeys, and ducks (International Programme on Chemical Safety, 2000; Tardieu et al., 2004 Tardieu et al., , 2007 Tran et al., 2005) . Although fumonisin B (FB) 1 (FB 1 ) is the most abundant fumonisin, short-term carcinogenesis studies in rat liver bioassay indicated that FB 2 and FB 3 closely mimic the toxicological and cancer-initiating activity of FB 1 and thus could contribute to the toxicological effects of fumonisin in animals (Gelderblom et al., 1992) . In the face of these problems, several recommendations and regulations have been made by the Food and Drug Administration, Joint FAO/WHO Expert Committee on Food Additives, and European Union to limit FB 1 , FB 2 , and FB 3 in food consumed by humans and animals (FDA, 2001; JECFA, 2002; European Communities, 2006) .
Quantification of fumonisins in vegetal food is relatively well documented. Most of the analytical techniques are based on fluorescence detection of derivatized fumonisins after their separation by HPLC (Shephard, 1998; AFNOR, 2002) . A new sophisticated method for analysis of fumonisins is reverse-phase HPLC/ electrospray ionization ion trap mass spectrometry or reverse-phase HPLC/electrospray ionization tandem mass spectrometry because of the selectivity of these hyphenated techniques (Bartók et al., 2006; Zöllner and Mayer-Helm, 2006) . All of these methods permit the separation and quantification of FB 1 , FB 2 , and FB 3 in food and feeds. By contrast, measurement of fumonisins in plasma and tissues is poorly documented. Generally, fumonisins are considered to have low bioavailability and low persistence (International Programme on Chemical Safety, 2000) . In avian species, data concerning the toxicokinetics of only FB 1 are available in ducks, turkeys, and laying hens (Vudathala et al., 1994; Tardieu et al., 2008a Tardieu et al., , 2009 ; the toxicokinetics of other fumonisins are unknown in these species.
The purpose of this study was to describe the development of a method for the quantification of FB 2 in plasma. Subsequently, the method was investigated to study the toxicokinetics parameters of FB 2 in ducks and turkeys after intravenous and oral dosing.
MATERIALS AND METHODS

Preparation of FB 2 Calibrants
Standard FB 2 was purchased from Biopure (Tulln, Austria). This stock solution has a certified concentration [50.5 ng/mL in acetonitrile/water (1:1 vol/vol)] and was diluted with the same solvent to obtain solutions ranging from 1 to 2,500 ng/mL. All the solutions were stored in the dark at 4°C as recommended by the Toxicokinetics of fumonisin B 2 in ducks and turkeys I. Benlashehr ,* C. Repussard ,* J.-Y. Jouglar , † D. Tardieu ,* and P. Guerre * 1 manufacturer. The pure FB 2 used in the duck and turkey assays was purchased from Sigma (St. Louis, MO).
HPLC Analysis
Samples were derivatized in the presence of β-mercaptoethanol with o-phthaldialdehyde (Sigma) and injected in the chromatographic system as described previously (AFNOR, 2002; Tardieu et al., 2008b) . Ten standard solutions were injected in triplicate to check the linear range between 0 and 1,250 ng/ mL of FB 2 . Repeatability was assessed with a standard solution (0.625 mg/L) injected 8 times. The same standard solutions were tested over 1 wk to assess betweenrun precision (n = 6).
Extraction
Plasma samples (250 μL) were first mixed with 500 μL of borate buffer (0.1 M, pH 5.8) and 750 μL of acetonitrile (Scharlau Chemie S.A., Sentmenat, Spain). Samples were placed on a stir table for 30 min at 300 rpm and then centrifuged at 3,000 × g for 15 min at room temperature. A delipidation step was then achieved by solid phase extraction on Supelclean 3-mL LC18 columns (Sigma) successively conditioned by 3 mL of H 2 O, 3 mL of acetonitrile, and 3 mL of acetonitrile/ borate buffer, 0.1 M, pH 5.8 (vol/vol) . The deproteinized supernatants of the samples were passed through the C18 columns. The columns were then washed with 4 mL of borate buffer (pH 5.8) and 3 mL of acetonitrile and all the eluates were collected (approximately 8 mL) and vortexed. The totality of the eluates was then purified by strong anion exchange solid phase extraction according to Shephard and Snijman (1999) . Finally, the samples were eluted by methanol/acetic acid (100:1 vol/vol) and were evaporated at 40°C in the dark under a gentle stream of nitrogen. The dry residue was resuspended with 250 μL of acetonitrile/water (1:1 vol/vol).
Validation of the Whole Method
Blank plasma samples obtained from ducks fed mycotoxin-free feed were fortified with different levels of FB 2 to determine the recovery rate, linearity and limit of detection (LOD), and limit of quantification (LOQ) of the whole method in plasma. Ten samples of unfortified plasma were analyzed to measure the noise ratio baseline in the range of retention time of FB 2 . The LOD was defined as the smallest FB 2 amount that yielded a signal 3 times higher than the noise ratio obtained with blank plasma.
Fortified samples were analyzed in triplicate to measure the recovery rates and to confirm the linearity of the method previously obtained using standard solutions. The LOQ was then defined as the smallest amount of compound for which the method was validated with sufficient accuracy.
Birds: Experimental Protocol
All experimental procedures using birds were in accordance with the French national guidelines for the care and use of animals for research purposes. The absence of the principal mycotoxins in feed was controlled by chromatographic techniques or ELISA kits (levels of fumonisins, aflatoxin B 1 , ochratoxin A, zearalenone, deoxynivalenol, and T2 toxin were below 100, 10, 10, 50, 250, and 50 μg/kg, respectively).
Five male mule ducks (10 wk of age, weighing approximately 2 kg; Pygavi, Muret, France) and 5 B.U.T. 9 turkeys (6-7 wk of age, weighing approximately 2 kg; GFA, Pierrepont, France) received an intravenous (IV) dose (1 mg/kg of BW) of FB 2 in NaCl 0.9% at an injection volume of 1 mL/kg of BW. Blood samples (2 mL) were taken 0, 3, 10, 20, 30, 45, 60, 90, 120 , and 240 min after administration of the toxin.
For the studies by oral route, 8 ducks and 8 turkeys received 10 mg of FB 2 /kg of BW at a volume of 10 mL/ kg. Blood samples (2 mL) were taken 30, 60, 120, 180, 300, 420, and 600 min after administration of the toxin.
All blood samples were removed from the jugular vein into EDTA tubes and centrifuged for 15 min at 3,000 g. The plasma was removed and stored at −20°C until use.
Data Analysis
The FB 2 plasmatic concentrations after IV dosing were plotted against time. The curves were fitted by nonlinear least squares analysis with SigmaPlot software (Systat Software Inc., Chicago, IL). The plasma curve of FB 2 obtained for each bird after a single IV dose was fitted using the 2-compartment models according to the following exponential equation (2 exponentials model):
where f is the function that describes the change in plasma concentration over time (x), A and B are mathematical coefficients, α is the rate constant for the distribution phase, and β is the rate constant for the terminal elimination phase. Toxicokinetics parameters after IV dosing were determined according to the following equations for each bird and were expressed as mean ± SE.
Area under the concentration time curves (AUC) was calculated as follows:
Total plasma clearance (Cl) was calculated as follows: Cl = dose (mg/kg)/AUC (IV dosing). Volume of distribution at steady state (Vd ss ) was determined as follows:
Vd ss = MRT × Cl (all cases).
RESULTS
Validation of the HPLC Method
The response of the detector to the concentration of FB 2 (in ng/L) was linear for the range of concentrations tested (12.5-1,250 ng/mL), with a correlation coefficient of 0.995 and a variation coefficient of the response factor lower than 10%. The repeatability of the standard FB 2 solutions (625 ng/mL; n = 6) was 3.79%. The interday reproducibility (n = 6) was 5.46%.
A good linearity (R 2 = 0.994) of the whole method was obtained for FB 2 concentrations in plasma ranging from 25 to 250 ng of FB 2 /mL. All samples with higher FB 2 concentrations must be diluted and reanalyzed. The LOD defined as the smallest FB 2 amount that yielded a signal 3 times higher than the noise ratio (obtained with blank plasma) was estimated at around 10 ng of FB 2 /mL for plasma. The LOQ, defined as the smallest amount of the compound for which the method was validated with sufficient accuracy, was 25 ng of FB 2 /mL of plasma. The mean of recovery rates of FB 2 from plasma for each level of contamination was 63 ± 5%.
Toxicokinetics of FB 2 in Ducks
No sign of pathology or disease was observed in birds during the study. Figure 1 shows the decrease of the FB 2 concentrations in plasma occurring with time after the IV dose of 1 mg/kg. Two hours after dosing, the plasmatic concentration of FB 2 was under the LOQ. The elimination of FB 2 from plasma was fitted according to a biexponential equation:
The function (f) describes the change in plasma concentration of FB 2 with time (x), A and B are the intercepts at the y-axis obtained from the semilogarithmic plot of plasma concentration against time, and α and β are the rate constants of the exponential components of the curve. The high coefficient of correlation obtained for each duck (higher than 0.9995) reveals that the model is representative of the elimination of FB 2 from plasma in this species.
Toxicokinetics parameters were determined as described in Methods and reported in Table 1 . The distribution phase was rapid (half-life time of distribution = 3.8 min) and followed by a slower terminal phase of elimination (half-life time of elimination = 32 min). The total plasma clearance of FB 2 was 9.3 mL/min per kilogram. The MRT was 12.9 min ( Table 1 ). The volume of the central compartment and the volume of distribution at the steady stage were low (61 and 120 mL/kg, respectively). The apparent volume of distribution was higher, approximately 0.4% of BW. Only traces of FB 2 , below the LOQ, were detected in plasma after oral dosing.
Toxicokinetics of FB 2 in Turkeys
No sign of pathology or disease was observed in birds during the study. After IV administration in turkeys (1 mg/kg), the FB 2 concentration in plasma decreased with time and were under the LOQ of the analytic method 1 h after dosing (Figure 2) .
The elimination of FB 2 from plasma was fitted according to a biexponential equation:
Half-life times of distribution and elimination were 1 and 12.4 min, respectively. Total plasma clearance was 8.7 mL/min per kilogram, whereas MRT was 5 min. The volume of the central compartment and the volume of distribution at the steady stage were very low, less than 0.1% of BW. The apparent volume of distribution was 154 mL/min per kilogram.
After the oral administration of 10 mg/kg of BW, only 2 turkeys showed plasmatic levels of FB 2 higher than the LOQ. These values were below 50 ng/mL and cannot be fitted by exponential equation.
DISCUSSION
The method of analysis used for the quantification of FB 2 in plasma was near the described method for FB 1 analysis in plasma and tissues (Tardieu et al., 2008b) . The linearity, repeatability, reproducibility, and LOQ agree with data obtained for FB 1 . Also, these results are within the same ranges as those obtained by using a strong-anion exchange column for the extraction of fumonisins from plasma (Shephard et al., 1995) .
Like FB 1 , the elimination of FB 2 from plasma in ducks and turkeys can be fitted according to a biex- 3.8 ± 1.6 1 ± 0.2 T1/2β (min) 32 ± 11 12.4 ± 6 AUC (ng/mL per min) 107, 303 ± 4, 439 115, 470 ± 477 MRT (min) 12.9 ± 5.1 5.0 ± 3.2 Cl (mL/min per kg) 9.3 ± 1.2 8.7 ± 0.7 Vd area (mL/kg) 442 ± 73 154 ± 88 V c (mL/kg) 61 ± 12 16 ± 10 Vd ss (mL/kg) 120 ± 32 43 ± 9 1 A, B: mathematical coefficients; α: rate constant for the distribution phase; β: rate constant for the elimination phase; T1/2α: distribution half-life; T1/2β: terminal elimination half-life; AUC: area under plasma concentration time curve from t = 0 to infinity; MRT: mean residence time; Cl: total plasma clearance; Vd area : volume of distribution; V c : volume of the central compartment; Vd ss : volume of distribution at the steady state. ponential equation (Tardieu et al., 2008a (Tardieu et al., , 2009 ). The distribution phase was short in both species, which agrees with the half-life time of distribution obtained for FB 1 (0.3 and 0.6 min in ducks and turkeys, respectively). The elimination half life and the MRT of FB 2 were more important in ducks than in turkeys, which explained why FB 2 can be quantified 2 h after dosing in ducks whereas the toxin was below the LOQ 1 h after dosing in turkeys. Nevertheless, the values of these parameters are lower than those obtained for FB 1 in ducks and turkeys, suggesting that persistence of FB 2 in tissues will not be more pronounced than FB 1 (Tardieu et al., 2008a (Tardieu et al., , 2009 .
The volume of the central compartment was small in both species, in agreement with data obtained for FB 1 in ducks and turkeys (Tardieu et al., 2008a (Tardieu et al., , 2009 ). The apparent volume of distribution was higher in ducks than in turkeys (0.44 and 0.15 L/kg, respectively). These results agree with those obtained for FB 1 after IV dosing in the same species. These results also agree with the longer MRT obtained for FB 2 in ducks compared with turkeys.
Concerning the clearance, no significant difference was obtained between ducks and turkeys, in contrast with data obtained for FB 1 (Tardieu et al., 2008a (Tardieu et al., , 2009 ). The clearance of FB 2 in ducks and turkeys was near the clearance of FB 1 in turkeys (values of 9.3, 8.7, and 8.7 mL/min per kg, respectively). This value is lower than the clearance obtained for FB 1 in ducks (19.3 mL/min per kg). Although this result is difficult to interpret, it could reveal that the persistence of FB 2 in duck tissue could be higher than the persistence of FB 1 . However, the lack of FB 2 detection after oral dosing in ducks demonstrates that the absorption of FB 2 is very low. In ducks and turkeys, a bioavailability of 2 and 3.2%, respectively, was obtained for FB 1 (Tardieu et al., 2008a (Tardieu et al., , 2009 .
Taken together, these results demonstrated that, in ducks and turkeys, the toxicokinetics parameters of FB 2 are not strongly different from the toxicokinetics parameters of FB 1 . Because FB 1 is the most abundant of the fumonisins in feed, monitoring its persistence in tissues would be sufficient to assess the safety of duck and turkey production for human consumers.
